Webster is Professor of Public Policy and Management at the University of Stirling Business School, and has worked with the ...

Key market opportunities in oncology clinical trials include personalized treatment demand, advancements in AI-driven solutions for data analysis and patient recruitment, and growth in the ...

Key market opportunities in the omics-based clinical trials sector include the rising adoption of personalized medicine, ...

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, ...

Motor neuron diseases, such as amyotrophic lateral sclerosis (ALS) and hereditary spastic paraplegia (HSP), share physical similarities but have been largely viewed as genetically distinct.

You can use the form below to sign up for email alerts about new positions as they open. Fields marked with an asterisk (*) are required. Genomics England partners with the NHS to provide whole genome ...

Announced in late 2025, the UK’s digital ID cards are designed to simplify the process of updating personal information and ...

Professor William Webster, an expert in surveillance at the University of Stirling, has been appointed as the new Biometrics and Surveillance Camera Commissioner. An internationally renowned expert in ...

Could artificial intelligence help dairy cattle farmers spot sickness in calves before it spreads and becomes deadly?

INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...

The U.K. Medicines and Healthcare products Agency (MHRA) has committed to major reforms of how it regulates drugs for rare ...

UK universities are a vital economic asset, but they are also Britain's 'equivalent of Gulf oil.' There are opportunities here for investors, says Matthew Partridge ...